Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury

doi:10.5492/wjccm.v14.i4.103782

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (194)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-6)

Sum=106

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=67

Dec 9, 2025 (publication date) through Dec 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Crit Care Med. Dec 9, 2025; 14(4): 103782
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.103782

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow cytometry analysis of exosomes. FITC-A: Fluorescein isothiocyanate-area; PE-A: Phycoerythrin-area; APC-A: Allophycocyanin-area.

Open in New Tab Full Size Figure Download Figure

Figure 2 Nanoparticle tracking analysis of exosomes. FTLA: Fitted track length average.

Open in New Tab Full Size Figure Download Figure

Figure 3 Changes observed in the pre-test and post-test means of the patients' functional independence measure Motor and Cognitive scores.

Open in New Tab Full Size Figure Download Figure

Figure 4 Changes observed in the pre-test and post-test means of the patients' Modified Ashworth Grading Right and Left values.

Open in New Tab Full Size Figure Download Figure

Figure 5 Changes observed in the pre-test and post-test means of the Karnofsky Performance Scale values of the patients.

Citation: Kabatas S, Civelek E, Savrunlu EC, Kaplan N, Akkoc T, Küçükçakır N, Bozkurt M, Karaöz E. Efficacy and safety of exosomes from Wharton’s Jelly-derived mesenchymal stem cells in traumatic brain injury. World J Crit Care Med 2025; 14(4): 103782
URL: https://www.wjgnet.com/2220-3141/full/v14/i4/103782.htm
DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.103782